A multidrug efflux pump inhibitor reduces Fluoroquinolone resistance in Pseudomonas aeruginosa isolates

Chemotherapy

Volumn 50, Issue 1, 2004, Pages 22-26

  Coban, Ahmet Yilmaz ^a   Ekinci, Bora ^a   Durupinar, Belma ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Efflux pump inhibitor; Fluoroquinolone resistance; Pseudomonas aeruginosa

Indexed keywords

CIPROFLOXACIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); LEVOFLOXACIN; OFLOXACIN; PHENYLALANYLARGININE 2 NAPHTHYLAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONCENTRATION RESPONSE; DRUG INHIBITION; IN VITRO STUDY; MULTIDRUG RESISTANCE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REDUCTION;

BACTERIAL OUTER MEMBRANE PROTEINS; CIPROFLOXACIN; DIPEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; MEMBRANE TRANSPORT MODULATORS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; PSEUDOMONAS AERUGINOSA;

EID: 1842830032     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077280     Document Type: Article

References (23)

1. Poole K: Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria. Antimicrob Agents Chemother 2000;44:2233-2241.
2. Evans K, Poole K: The MexA-MexB-OprM multidrug efflux system of Pseudomonas aeruginosa is growth-phase regulated. FEMS Microbiol Lett 1999;173:35-39.
3. Zhang L, Li XZ, Poole K: Fluoroquinolone susceptibilities of efflux-mediated multidrug-resistant Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia. J Antimicrob Chemother 2001;48:549-552.
4. Poole K: Multidrug resistance in gram-negative bacteria. Curr Opin Microbiol 2001;4:500-508.
5. Webber MA, Piddock LJV: The importance of efflux pumps in bacterial antibiotic resistance. J Antimicrob Chemother 2003;51:9-11.
6. Bolhuis H, van Veen HW, Poolman B, Driessen AJM, Konings WN: Mechanisms of multidrug transporters. FEMS Microbiol Rev 1997;21:55-84.
7. Putman M, van Veen HW, Konings WN: Molecular properties of bacterial multidrug transporters. Microbiol Mol Biol Rev 2000;64:672-693.
8. Li XZ, Zhang L, Poole K: Interplay between the MexA-MexB-OprM multidrug efflux system and the outer membrane barrier in the multiple antibiotic resistance of Pseudomonas aeruginosa. J Antimicrob Chemother 2000;45:433-436.
9. Li XZ, Poole K: Mutational analysis of the OprM outer membrane component of the MexA-MexB-OprM multidrug efflux system of Pseudomonas aeruginosa. J Bacteriol 2001;183:12-27.
10. De Kievit TR, Parkins MD, Gillis RJ, Srikumar R, Ceri H, Poole K, Iglewski BH, Storey DG: Multidrug efflux pumps: Expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 2001;45:1761-1770.
11. Li XZ, Barre N, Poole K: Influence of the MexA-MexB-OprM multidrug efflux system on expression of the MexC-MexD-OprJ and MexE-MexF-OprN multidrug efflux systems in Pseudomonas aeruginosa. J Antimicrob Chemother 2000;46:885-893.
12. Srikumar R, Paul CJ, Poole K: Influence of mutations in the mexR repressor gene on expression of the MexA-MexB-OprM multidrug efflux system of Pseudomonas aeruginosa. J Bacteriol 2000;182:1410-1414.
13. Ainsa JA, Blokpoel MC, Otal I, Young DB, De Smet KA, Martin C: Molecular cloning and characterization of Tap, a putative multidrug efflux pump present in Mycobacterium fortuitum and Mycobacterium tuberculosis. J Bacteriol 1998;180:5836-5843.
14. Piddock LJ, Williams KJ, Ricci V: Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis. J Antimicrob Chemother 2000;45:159-165.
15. Lomovskaya O, Warren MS, Lee A, Galazzo J, Fronko R, Lee M, Blais J, Cho D, Chamberland S, Renau T, Leger R, Hecker S, Watkins W, Hoshino K, Ishida H, Lee VJ: Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: Novel agents for combination therapy. Antimicrob Agents Chemother 2001;45:105-116.
16. Silva PE, Bigi F, de la Paz Santangelo M, Romano MI, Martin C, Cataldi A, Ainsa JA: Characterization of P55, a multidrug efflux pump in Mycobacterium bovis and Mycobacterium tuberculosis. Antimicrob Agents Chemother 2001;45:800-804.
17. National Committee for Clinical Laboratory Standards (NCCLS): Methods for Dilution Antimicrobial Susceptibility Test for Bacteria That Grow Aerobically. Approved standard M7-A4, ed 4. Wayne, National Committee for Clinical Laboratory Standards, 1997.
18. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC Jr: Color Atlas and Textbook of Diagnostic Microbiology, ed 5. New York, Lippincott, 1997, chap 15:Antimicrobial susceptibility testing, pp 785-856.
19. Lomovskaya O, Watkins W: Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria. J Mol Microbiol Biotechnol 2001;3:225-236.
20. Ribera A, Ruiz J, de Anta MTJ, Vila J: Effect on an efflux pump inhibitor on the MIC of nalidixic acid for Acinetobacter baumannii and Stenotrophomonas maltophilia clinical isolates. J Antimicrob Chemother 2002;49:697-702.
21. Li XZ, Zhang L, Srikumar R, Poole K: β-Lactamase inhibitors are substrates for the multidrug efflux pumps of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1998;42:399-403.
22. Lomovskaya O, Lee A, Hoshino K, Ishida H, Mistry A, Warren MS, Boyer E, Chamberland S, Lee VJ: Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1999;43:1340-1346.
23. Lee MD, Galazzo JL, Staley AL, Lee JC, Warren MS, Fuernkranz H, Chamberland S, Lomovskaya O, Miller GH: Microbial fermentation-derived inhibitors of efflux-pump-mediated drug resistance. Farmaco 2001;56:81-85.